Drawing for BIOFIRE DIAGNOSTICS, INC.

USPTO serial 85699250

BIOFIRE DIAGNOSTICS, INC.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
ROBERTSON, DEIRDRE G
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOFIRE DIAGNOSTICS, INC.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy O. Dix

Nancy O. Dix DLA Piper LLP (US)401 B Street, Suite 1700San Diego, CA 92101-4297UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biochemical and chemical reagents used for non-medical purposes; Diagnostic reagents for scientific or research use; Freeze-dried reagents for purification of DNA/RNA; Chemical products, namely, reagents, control solutions and control reagents, buffers, dyes and kits comprised of the foregoing, for scientific, research, industrial, quality control and calibration purposes, and for laboratory and field use in the environmental fields for treating environments or for use in testing the condition of environments, testing food, water, blood, air, and other liquids, powders and substances, for use with scientific and research apparatus, and for use in rapid screening, biological processing and assay analysis; Enzymes for industrial use, namely, testing food, water, blood, air, and other liquids, powders and substances; DNA genetic primers, DNA nucleic acid primers, biochemical reagents commonly known as probes, genetic probes and nucleic acid probes for detecting and analyzing molecules in food, water, blood, air, and other liquids, powders and substances; enzymes for environmental diagnostic use, environmental clinical use, environmental laboratory use and industrial use; Diagnostic reagents, buffers, dyes, and kits comprised of the foregoing, for scientific or research use in the biological, pathological, genetic, bio-defense and bio-surveillance fields; Control solutions, control reagents, buffers and diagnostic agents and preparations for scientific or research use in the biological, pathological, genetic, environmental, clinical diagnostic, bio-defense and bio-surveillance fields, and for laboratory useACTIVE
005Diagnostic reagents, buffers, dyes, and kits comprised of the foregoing, for use in the medical and veterinary fields; Control solutions, control reagents, buffers and diagnostic agents and preparations for clinical medical, medical, and veterinary useACTIVE
009Laboratory devices, apparatus and instruments, namely, imaging devices comprising fluorimeters used to record fluorescence signals and produce data, thermal control elements for heating and cooling, light emitters such as lasers and light bulbs, lenses, mirrors, stations for placement of microtiter plates, microtiter plate readers; Laboratory materials, articles and disposable, namely, optical filters, computer chips, thermal control elements for heating and cooling, sample containers, transformer connectors, batteries, battery chargers, testing sample pouches, testing sample pouch holders, syringes and plungers, carrying packs specially adapted for carrying all of the above-named goods, plastic or other sampling vials, plastic or other preparation vials; Computer software, computer programs and associated instruction manuals all for use in detecting, identifying, classifying, tagging, labeling, amplifying, testing, analyzing, determining sequence, evaluating, monitoring, purifying, counting, mapping, engineering, expressing, measuring, preparing, testing, mixing, heating and cooling chemical, biochemical, biological, genetic, pathological and toxic agents, pathogens, bacteria, germs, viruses, diseases, contagions, materials and samples; Computer software, computer programs and computer firmware all for use in controlling processes, inputting, analyzing, modifying, transferring, displaying, reporting and storing data and results; Laptop computers, hard drives for computers and computer hardware; Probes for environmental purpose; Analytical instruments, namely, a laboratory instrument combining a rapid air thermocycling apparatus and a fluorimeter; laboratory equipment, namely, units for the purification and amplification of nucleic acids and devices used to heat and cool biological samples; Bio-defense and bio-surveillance systems and instruments, and food and water security testing systems and instruments, namely, imaging devices comprising fluorimeters used to record fluorescence signals and produce data, thermal control elements for heating and cooling; Scientific apparatus and instruments for measuring DNA, RNA and protein and parts and fittings thereforACTIVE
010Medical apparatus, devices, equipment and instruments, namely, imaging devices comprising fluorimeters used to record fluorescence signals and produce data, thermal control elements for heating and cooling, scanners, microtiter plate readers, stations for placement of microtiter plates, lenses, mirrors, computers, instrument software, analytical software, and cases to hold the foregoing, all for detecting, identifying, classifying, analyzing, evaluating, monitoring, preparing, testing, mixing, heating and cooling nucleic acid, cells, genes and chemical, biochemical, biological, genetic, pathological and toxic materials and samples for medical, clinical and diagnostic purposes; medical materials, articles, apparatus and disposable items, namely, thermal control elements for heating and cooling, containers specially adapted for medical use to hold samples for testing purposes, tubes specially adapted for medical use for testing purposes, microtiter plates, plastic and metal receiver cartridges all for medical, surgical, veterinary, clinical and diagnostic use; Nucleic acid amplifiers for medical useACTIVE
042Development of technology for others in the fields of biotechnology and biochemistry; Scientific and laboratory research, design, development, testing, and diagnostics in the fields of biotechnology and biochemistry; Scientific and laboratory sample scanning, product development, software development and maintenance, online information and consulting services in the fields of biotechnology and biochemistryACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 14, 2014MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 14, 2014ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 10, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 17, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 16, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 16, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 26, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 6, 2013ALIEASSIGNED TO LIE
May 22, 2013ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 20, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 20, 2013XAECEXAMINER'S AMENDMENT ENTERED
May 20, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 20, 2013GNEAEXAMINERS AMENDMENT E-MAILED
May 20, 2013CNEAEXAMINERS AMENDMENT -WRITTEN
May 17, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 7, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 6, 2012DOCKASSIGNED TO EXAMINER
Aug 17, 2012MPMKNOTICE OF PSEUDO MARK MAILED
Aug 16, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2012NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance